Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents – News-Medical.Net
TrustVaccines
via vaccines https://ift.tt/f7Z2Kbp
March 21, 2022 at 09:39AM
Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents – News-Medical.Net
Welcome to vaccine education 